Co-administered antibody improves penetration of antibody–dye conjugate into human cancers with implications for antibody–drug conjugates

Poor tissue penetration remains a major challenge for antibody-based therapeutics of solid tumors, but proper dosing can improve the tissue penetration and thus therapeutic efficacy of these biologics. Due to dose-limiting toxicity of the small molecule payload, antibody-drug conjugates (ADCs) are a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Guolan, Nishio, Naoki, van den Berg, Nynke S., Martin, Brock A., Fakurnejad, Shayan, van Keulen, Stan, Colevas, Alexander D., Thurber, Greg M., Rosenthal, Eben L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652891/
https://www.ncbi.nlm.nih.gov/pubmed/33168818
http://dx.doi.org/10.1038/s41467-020-19498-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652891/
https://www.ncbi.nlm.nih.gov/pubmed/33168818
http://dx.doi.org/10.1038/s41467-020-19498-y

Ejemplares similares